MRI is the standard of care for most neuroimaging indications, and advanced sequences are providing an ever-growing ability for lesion characterisation. PET is widely used in oncology, and the limitations of Fluorine-18 fluorodeoxyglucose in neuro-oncology have been overcome by the development of novel PET tracers. The sequential use of these modalities harnesses the strengths of both, and has led to the development of combined PET-MR systems. This educational exhibit demonstrates the ways in which MRI and PET can be used in a complementary manner for improved lesion characterisation in neuro-oncology, including diagnosis and treatment planning.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords